Results 191 to 200 of about 9,793 (303)

REAL-WORLD IMPACT OF LONG-TERM PROPHYLAXIS ON THE CLINICAL BURDEN OF PATIENTS WITH HEREDITARY ANGIOEDEMA [PDF]

Cristine Radojicic, Art Zbrozek, Montserrat Vera‐Llonch, Philippe Thompson‐Leduc, Marjolaine Gauthier‐Loiselle, Anabelle Tardif‐Samson, Claire Vanden Eynde, Aurélie Guérin, W. Lumry   +8 more
openalex   +1 more source

Double‐Blind Placebo Challenge Confirmation of Diphenhydramine Allergy

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Diphenhydramine, a first‐generation H1–antihistamine commonly used for allergic symptom relief and infusion premedication, rarely causes true systemic hypersensitivity. When suspected reactions are mild and subjective—particularly in anxious patients—objective confirmation is essential.
Ruchi Patel, Aleena Mahmood, Eugenio Capitle   +2 more
wiley   +1 more source

Safety evaluation of inactivated poliomyelitis vaccine. [PDF]

Hum Vaccin Immunother
Yan D, Yunji L, Jiawei L, Jiarong L, Junyan L, Pinyi H, Yufan Y, Jianxin Z, Zhilei Z, Jingsi Y.   +9 more
europepmc   +1 more source

Risk factors associated with severe and recurrent angioedema: An epidemic linked to ACE‐inhibitors [PDF]

, 2014
Patricia A. Loftus, Melin Tan, G. Patel, Juan Lin, Sam Helman, Arvind Badhey, Eugenie Du, Richard V. Smith, Marvin P. Fried, Thomas J. Ow   +9 more
openalex   +1 more source

Effect of Post‐Ablational Angiotensin Receptor‐Neprilysin Inhibitor on Atrial Fibrillation Recurrence: A Systematic Review and Meta‐Analysis in Asian Population

Clinical Cardiology, Volume 49, Issue 4, April 2026.
In this meta‐analysis of randomized controlled trials and cohort studies comparing angiotensin receptor‐neprilysin inhibitor (ARNI), angiotensin‐converting enzyme inhibitor and/or angiotensin receptor blocker (ACEI/ARB), and no‐treatment control, the use of ARNI may be effective in preventing the recurrence of atrial fibrillation (AF) after ablation ...
Yangyang Wang, Wenjing Zhang, Yang Shao, Qiming Dong, Yunfei Gu, Hao Wang   +5 more
wiley   +1 more source

Hereditary Angioedema Prophylaxis Therapy: Berotralstat and Lanadelumab Safety Profile. [PDF]

Medicina (Kaunas)
Donadoni M, La Cava L, Bizzi E, Popescu Janu V, Meschia A, Cirigliano F, Cogliati C, Gidaro A.   +7 more
europepmc   +1 more source

SUSTAINED REAL-WORLD ATTACK REDUCTIONS FOLLOWING BEROTRALSTAT INITIATION AMONG PATIENTS WITH HEREDITARY ANGIOEDEMA WITHOUT C1-INHIBITOR DEFICIENCY [PDF]

Mark Davis‐Lorton, R. Tachdjian, Lorena López-González, Sean D. MacKnight, François Laliberté, C Martínez, Pieter Gillard, W. Lumry   +7 more
openalex   +1 more source

Acquired Angioedema [PDF]

Deutsches Ärzteblatt international, 2017
openaire   +2 more sources

Isolation, Purification, Identification, and In Vitro ACE Inhibitory Activity of Tyrosine‐Arginine Dipeptide From Red Millet Huangjiu

Food Science &Nutrition, Volume 14, Issue 4, April 2026.
This study identified a novel ACE inhibitory dipeptide, Tyr‐Arg (YR), from red millet Huangjiu using multi‐step purification and ESI‐MS/MS. Tyr‐Arg exhibited effective inhibitory activity with an IC50 of 158.93 ± 0.39 μM. Molecular docking and 100‐ns molecular dynamics (MD) simulations revealed a non‐competitive inhibition mechanism, where Tyr‐Arg ...
Jie Li, Junhui Zhong, Xin Zhang
wiley   +1 more source

Management of Hereditary Angioedema in Pediatric, Pregnant, and Breast-Feeding Patients: An Expert Opinion – A Secondary Publication

Sun Young Yoon, Jae‐Woo Jung, So‐Young Park, Gun-Woo Kim, Kyunghee Son, Sung‐Yoon Kang, Hye Jung Park, Min-Kyu Kang, Joo‐Hee Kim, Kyung Hee Park, Dong Hun Lee, Sae‐Hoon Kim, Hyouk‐Soo Kwon, Hye‐Ryun Kang, Dong In Suh   +14 more
openalex   +2 more sources